Get an alert when EXACT SCIENCES UK, LTD. files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Next accounts due

2026-09-30 (in 4mo)

Last filed for 2024-12-31

Confirmation statement due

2026-07-31 (in 2mo)

Last made up 2025-07-17

Watchouts

None on the register

Cash

£5M

+4.9% vs 2023

Net assets

£6M

+7.1% vs 2023

Employees

22

+15.8% vs 2023

Profit before tax

£553K

+2.5% vs 2023

Name history

Renamed 1 time since incorporation

  1. EXACT SCIENCES UK, LTD. 2019-11-25 → present
  2. GENOMIC HEALTH UK, LTD. 2011-01-06 → 2019-11-25

Accounts

2-year trend · latest reflected 2024-12-31

Metric Trend 2023-12-312024-12-31
Turnover £13,552,735£13,934,787
Operating profit £540,083£551,187
Profit before tax £539,313£552,718
Net profit £381,386£391,586
Cash £4,743,929£4,978,027
Total assets less current liabilities £5,496,740£5,888,326
Net assets £5,496,740£5,888,326
Equity £5,496,740£5,888,326
Average employees 1922
Wages £2,397,091£2,608,938

Values shown as filed in the company's annual accounts. indicates the figure wasn't present under that line item in that period. About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2023-12-312024-12-31
Operating margin 4.0%4.0%
Net margin 2.8%2.8%
Return on capital employed 9.8%9.4%
Current ratio 3.52x3.45x
Interest cover 701.41x

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Audit & accounting basis

Accounting basis
FRS 102
Reporting scope
Standalone (parent only)
Auditor
BDO LLP
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“The directors have considered the ability of the Company to continue as a going concern, and have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future. Thus they continue to adopt the going concern basis of accounting in preparing the annual financial statements.”

Significant events

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

5 active · 19 resigned

Name Role Appointed Born Nationality
HERRIOTT, James Michael John Director 2022-06-30 Mar 1980 American
HOTTMANN, Katherine Ava Miller Director 2025-07-01 Aug 1985 American
ROBERTS, Andrew James Director 2025-04-01 Mar 1974 British
SLATER, Bradley Jay Director 2026-03-25 Mar 1969 American
WENNER, James Russell Director 2026-03-25 Sep 1967 American
Show 19 resigned officers
Name Role Appointed Resigned
ABOGADO NOMINEES LIMITED Corporate Secretary 2011-01-06 2023-09-13
GRAVITAS COMPANY SECRETARIAL SERVICES LIMITED Corporate Secretary 2023-09-13 2024-07-09
BULL, Matthew Director 2024-09-10 2025-04-01
COLE, Gordon Bradley Director 2014-06-26 2017-01-19
CONROY, Kevin Thomas Director 2019-11-11 2024-09-10
COWARD, David Scott Director 2019-11-11 2022-12-13
ELLIOTT, Jeffrey Thomas Director 2019-11-11 2024-09-10
HIBBS, Kathy Director 2011-01-06 2014-03-27
HOGAN, Brian Patrick Director 2017-01-19 2017-09-15
LA REGINA, Antonio Director 2022-06-30 2024-09-10
MCEACHRON, Kim Ellen Director 2014-04-29 2017-01-19
OGRAM, Stephen John Director 2016-05-23 2023-08-25
PETIT, Stéphane Marcel Pierre Director 2022-06-30 2023-06-30
PITHERS, Andrea Benson Director 2015-02-26 2016-05-23
RADFORD, Jason William Director 2017-09-15 2019-11-11
SCHORNO, Dean Lawrence Director 2011-01-06 2014-06-25
STACEY, Kyle Andrew Director 2019-11-11 2025-07-01
TRUELOVE, Jonathan Andrew Kindred Director 2017-01-19 2024-09-10
GENOMIC HEALTH, INC. Corporate Director 2011-01-06 2016-05-23

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
Exact Sciences Corp. Corporate entity Shares 75–100%, Voting 75–100%, Appoints directors 2019-11-08 Active
Genomic Health, Inc. Corporate entity Shares 75–100%, Voting 75–100%, Appoints directors 2016-04-06 Ceased 2019-11-08

Filing timeline

Last 20 of 94 total filings

Date Type Category Description
2026-04-02 AP01 officers Appoint person director company with name date PDF
2026-04-02 AP01 officers Appoint person director company with name date PDF
2025-12-17 AD04 address Move registers to registered office company with new address PDF
2025-11-24 AA accounts Accounts with accounts type full
2025-07-18 CS01 confirmation-statement Confirmation statement with no updates PDF
2025-07-01 AP01 officers Appoint person director company with name date PDF
2025-07-01 TM01 officers Termination director company with name termination date PDF
2025-04-08 AP01 officers Appoint person director company with name date PDF
2025-04-08 TM01 officers Termination director company with name termination date PDF
2025-01-08 CS01 confirmation-statement Confirmation statement with no updates PDF
2024-11-12 AA accounts Accounts with accounts type full
2024-09-11 AP01 officers Appoint person director company with name date PDF
2024-09-11 TM01 officers Termination director company with name termination date PDF
2024-09-11 TM01 officers Termination director company with name termination date PDF
2024-09-11 TM01 officers Termination director company with name termination date PDF
2024-09-11 TM01 officers Termination director company with name termination date PDF
2024-07-13 AD03 address Move registers to sail company with new address PDF
2024-07-13 AD02 address Change sail address company with new address PDF
2024-07-09 AD01 address Change registered office address company with date old address new address PDF
2024-07-09 TM02 officers Termination secretary company with name termination date PDF

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
7

last 12 months

Capital events
0

last 24 months

Officers appointed
3

last 12 months

Officers resigned
1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Year-on-year

FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Official Companies House page